Your search returned 37 studies. (Get alerts for new studies):
- Pharmacokinetics/Pharmacodynamics of Albiglutide
Conditions: Diabetes Mellitus, Type 2
Location: Blue Ridge, Georgia
- Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease
Conditions: Haemophilus Infections - Diphtheria - Tetanus - Polio - Pertussis
Location: Jasper, Georgia
- Growth and Tolerance of Hypoallergenic Formulas
Conditions: Growth of Term Infants
Location: Dalton, Georgia
- Chronic Plaque Psoriasis (Ps) Registry
Conditions: Chronic Plaque Psoriasis
Location: Calhoun, Georgia
- Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled
Conditions: COPD - COPD Exacerbation - Lung Diseases - Respiratory Disorders - Pulmonary Disease - Chronic Obstructive Lung Diseases - Chronic Obstructive Airway Disease
Location: Dawsonville, Georgia
- Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypert
Conditions: Stage 1 Hypertension - Stage 2 Hypertension
Location: Blue Ridge, Georgia
- A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Conditions: Type 2 Diabetes Mellitus - Chronic Kidney Disease
Location: Blue Ridge, Georgia
- A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional A
Conditions: Type 2 Diabetes
Location: Blue Ridge, Georgia
- A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and rLP2086 Vaccine When Given at the Same Time to Children Bet
Conditions: Vaccines - Meningococcal Vaccines
Location: Dalton, Georgia
- FREEDOM: Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements Study
Conditions: Kidney Failure, Chronic - End Stage Renal Disease, Requiring Dialysis
Location: Chattanooga, Tennessee
- Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
Conditions: Arthritis, Rheumatoid
Location: Hixson, Tennessee
- A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Conditions: Atopic Dermatitis
Location: Chattanooga, Tennessee
- Juvenile Idiopathic Arthritis (JIA) Registry
Conditions: Juvenile Idiopathic Arthritis
Location: Hixson, Tennessee
- Chronic Plaque Psoriasis (Ps) Registry
Conditions: Chronic Plaque Psoriasis
Location: Hixson, Tennessee
- A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Conditions: Asthma
Location: Chattanooga, Tennessee
- Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus
Location: Athens, Tennessee
- Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Conditions: Diarrhea Predominant Irritable Bowel Syndrome
Location: Chattanooga, Tennessee
- A Study to Determine if There is a Possible Association Between Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) and Phosphodiesterase Type 5 (
Conditions: Nonarteritic Anterior Ischemic Optic Neuropathy
Location: Chattanooga, Tennessee
- Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Conditions: Acute Coronary Syndrome
Location: Blue Ridge, Georgia
- Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Conditions: Ovarian Cancer
Location: Chattanooga, Tennessee
- A Study of LY2127399 in Patients With Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus - Connective Tissue Disease - Autoimmune Disease
Location: Hixon, Tennessee
- Laparoscopic Gastric Plication Operation for Patients With Severe or Morbid Obesity
Conditions: Morbid Obesity
Location: Dalton, Georgia
- Laparoscopic Gastric Plication Operation for Patients With Severe or Morbid Obesity
Conditions: Morbid Obesity
Location: Chattanooga, Tennessee
- Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With Gastroparesis
Conditions: Gastroparesis
Location: Chattanooga, Tennessee
- Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Conditions: Cervical Dystonia - Blepharospasm
Location: Chattanooga, Tennessee
- A Study of RoActemra/Actemra (Tocilizumab) in Comparison to Etanercept in Patients With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors
Conditions: Cardiovascular Disease, Rheumatoid Arthritis
Location: Hixson, Tennessee
- A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
Conditions: Celiac Disease
Location: Chattanooga, Tennessee
- Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain
Conditions: Low Back Pain
Location: Blue Ridge, Georgia
- The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Conditions: Chronic Idiopathic Constipation
Location: Chattanooga, Tennessee
- A Study in Patients With Type I Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 1
Location: Chattanooga, Tennessee
- A Study in Participants With Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2
Location: Chattanooga, Tennessee
- Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy
Conditions: Type 2 Diabetes Mellitus
Location: Chattanooga, Tennessee
- A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Conditions: Irritable Bowel Syndrome
Location: Chattanooga, Tennessee
- Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
Conditions: Diabetic Peripheral Neuropathy
Location: Chattanooga, Tennessee
- A Safety Study of 3 Different Bowel Cleansing Preparations
Conditions: Colonoscopy - Bowel Preparation - Endoscopy
Location: Chattanooga, Tennessee
- Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On M
Conditions: Diabetes Mellitus, Type 2
Location: Chattanooga, Tennessee
- A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes
Conditions: Diabetes - Diabetes Mellitus, Type 2
Location: Chattanooga, Tennessee
|